2021-01-05,"Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference"
2020-12-15,Is RVMD A Good Stock To Buy Now?
2020-11-26,We Think Revolution Medicines (NASDAQ:RVMD) Can Afford To Drive Business Growth
2020-11-12,Revolution Medicines Reports Third Quarter 2020 Financial Results and Update on Corporate Progress
2020-10-24,Revolution Medicines Reports Progress and Expansion of Combination Strategy with RMC-4630 as Therapeutic Backbone for RAS-Addicted Cancers
2020-10-24,Cancer Meeting Could Ignite These Biotech Stocks
2020-10-12,Revolution Medicines to Present Interim Data at ENA 2020 from Phase 1b/2 Clinical Trial Combining RMC-4630 with Cobimetinib for RAS-Addicted Solid Tumors
2020-09-22,Revolution Medicines (RVMD) Looks Good: Stock Adds 6.9% in Session
2020-09-18,High Hopes for Amgen and Gilead at Europes Biggest Cancer Research Conference
2020-09-16,Revolution Medicines Reports Preclinical Tumor Regressions Induced by First-in-Class KRAS-G12D(ON) Inhibitors
2020-09-09,Revolution Medicines to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-09-08,Revolution Medicines to Participate in 2nd Annual RAS-Targeted Drug Development Conference
2020-08-28,"Here's What Revolution Medicines, Inc.'s (NASDAQ:RVMD) Shareholder Ownership Structure Looks Like"
2020-08-10,Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
2020-07-13,Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
2020-07-13,Revolution Medicines (RVMD) Catches Eye: Stock Jumps 10.2%
2020-07-06,Revolution Medicines Announces Proposed Public Offering of Common Stock
2020-06-30,Revolution Medicines Reports New Application of Tri-Complex Modality for Undruggable Protein Targets and Announces License to Ginkgo Bioworks to Explore Potential Use Against Novel Coronavirus
2020-06-22,Revolution Medicines Provides Research and Development Update for its Portfolio of Novel Targeted Cancer Therapies
2020-06-22,Revolution Medicines Announces Dosing of First Patient in Clinical Study of RMC-4630 (SAR442720) Combined with PD-1 Inhibitor
2020-06-18,"Revolution Medicines Appoints Eric T. Schmidt, Ph.D. and Peter Svennilson to its Board of Directors"
2020-06-09,Revolution Medicines Announces Dosing of First Patient in Phase 1b Combination Study of RMC-4630 and AMG 510
2020-05-22,Why Blackstone Stock Looks Attractive
2020-05-19,Revolution Medicines Announces Four Presentations at the 2020 American Association for Cancer Research Virtual Annual Meeting II
2020-05-14,Revolution Medicines Reports First Quarter 2020 Financial Results and Continued Corporate Progress
2020-04-29,Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
2020-03-18,Revolution Medicines Announces Issuance of U.S. Patent Covering Compositions of Matter for its Clinical-Stage SHP2 Inhibitor Program
2020-03-09,New Clinical Trial Exploring Revolution Medicines Investigational SHP2 Inhibitor RMC-4630 in Combination with an ERK Inhibitor Announced by Netherlands Cancer Institute
2020-02-18,Revolution Medicines Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares
2020-02-14,The Funded: 7 Bay Area startups raise over $135M at week's end
2020-02-13,Revolution Medicines shares soar 85% in trading debut after IPO priced at top end of range
2020-02-12,Revolution Medicines prices IPO at $17 a share
2020-02-12,Revolution Medicines Announces Pricing of Initial Public Offering
2020-02-11,Revolution Medicines increases size of planned IPO and raises price range
